Morphological and phylogenetic studies of two new neotropical species of Loweomyces (Polyporales, Basidiomycota)

The genus Loweomyces is characterized by resupinate to pileate, sessile to stipitate basidiomes, monomitic to dimitic hyphal system with presence of pseudoskeletal hyphae, thin-walled hymenial cystidia, and usually cyanophilous spore and hyphal walls. The genus has not been widely accepted and some authors placed Loweomyces species in Abortiporus, Tyromyces or Antrodiella. During a survey of polypores in southern Brazil, two unidentified species with similar features to Loweomyces spp. were found. Morphological and molecular studies were carried out in order to understand their morphological and evolutionary relationships and to confirm their phylogenetic placement and taxonomic identity. DNA sequences of the internal transcribed spacer and large subunit of ribosomal RNA gene were used for phylogenetic studies. Both studied species have similar morphological characteristics to other Loweomyces spp. and group close to L. fractipes phylogenetically; therefore, Loweomyces spissus and L. tomentosus are proposed as new species. Full descriptions, illustrations of microscopic features, and an identification key to the accepted species in the genus are presented.Fil: Westphalen, Mauro C.. Instituto de Botanica de Sao Paulo; BrasilFil: Tomšovský, Michal. Mendelova Univerzita V Brne; República ChecaFil: Rajchenberg, Mario. Centro de Investigación y Extensión Forestal Andino Patagónico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Gugliotta, Adriana M.. Instituto de Botanica de Sao Paulo; Brasi

New insights on Flaviporus (Polyporales) in the neotropics

The genus Flaviporus (Polyporales, Steccherinaceae) includes species of polypores with watery and resinous basidiomes that shrink and become very hard upon drying. Recent studies indicated that F. liebmannii, one of the most common species of the genus in the Neotropics, is polyphyletic. In addition, several names have been associated with Flaviporus in the past, but have not been revised and/or discussed recently. In this study, we aimed to identify monophyletic groups in the genus based on morphological features and a multigene molecular phylogeny. We prepared two different datasets to infer phylogenetic relationships, one based in four genes (ITS, ncLSU rDNA, TEF1-α, and RPB1) to evaluate the position of the genus within the Steccherinaceae, and a separate phylogeny based on two genes (ITS and ncLSU) to evaluate species-level boundaries within Flaviporus. Based on the data obtained, the new species Flaviporus lacteus is proposed. In addition, F. liebmannii is confirmed to form a species complex including at least two different species, F. liebmannii s.s., and F. subglobisporus comb. et stat. nov. Full descriptions of the new taxa proposed, as well as comments on all species accepted in the genus are provided.Fil: Westphalen, Mauro C.. Universidade Federal do Rio Grande do Sul; BrasilFil: Motato Vásquez, Viviana. Universidad del Valle; ColombiaFil: Rajchenberg, Mario. Centro de Investigación y Extensión Forestal Andino Patagónico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Tomšovský, Michal. Mendel University in Brno; República ChecaFil: Gugliotta, Adriana M.. Instituto de Pesquisas Ambientais; BrasilFil: Silveira, Rosa Mara Borges Da. Universidade Federal do Rio Grande do Sul; Brasi

Diversity of Brazilian Fungi

Abstract Knowledge about the Brazilian fungal diversity was, until 2010, recorded in few taxonomy and ecology publications, as well as in a handful of species lists. With the publication of the Catálogo de Plantas e Fungos do Brasil and the continued availability of an online list, it has been possible to aggregate this dispersed knowledge. The version presented here adds 2,111 species names to the 3,608 listed in 2010. A total of 5,719 species of fungi distributed in 1,246 genera, 102 orders and 13 phyla represents a considerable increase over the last five years, when only 924 genera and 78 orders were registered. Basidiomycota (2,741 species in 22 orders) and Ascomycota (1,881 species in 41 orders) predominate over other groups. The Atlantic Rainforest has the largest number of records, with 3,017 species, followed by Amazon Rainforest (1,050), Caatinga (999), Cerrado (638) and Pampa and Pantanal with 84 and 35 species, respectively. The Northeast region has the greatest richness (2,617 species), followed by Southeast (2,252), South (1,995), North (1,301) and Central-West (488 species). Regarding the States of the Federation, São Paulo with 1,846 species, Pernambuco with 1,611 and Rio Grande do Sul with 1,377 species are the most diverse

The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

There are different BCR-ABL1 fusion genes that are translated into proteins that are different from each other, yet all leukemogenic, causing chronic myeloid leukemia (CML) or acute lymphoblastic leukemia. Their frequency has never been systematically investigated. In a series of 45503 newly diagnosed CML patients reported from 45 countries, it was found that the proportion of e13a2 (also known as b2a2) and of e14a2 (also known as b3a2), including the cases co-expressing e14a2 and e13a2, was 37.9% and 62.1%, respectively. The proportion of these two transcripts was correlated with gender, e13a2 being more frequent in males (39.2%) than in females (36.2%), was correlated with age, decreasing from 39.6% in children and adolescents down to 31.6% in patients ≥ 80 years old, and was not constant worldwide. Other, rare transcripts were reported in 666/34561 patients (1.93%). The proportion of rare transcripts was associated with gender (2.27% in females and 1.69% in males) and with age (from 1.79% in children and adolescents up to 3.84% in patients ≥ 80 years old). These data show that the differences in proportion are not by chance. This is important, as the transcript type is a variable that is suspected to be of prognostic importance for response to treatment, outcome of treatment, and rate of treatment-free remission